Medical/Pharmaceuticals

Frost & Sullivan Awarded Duopharma Biotech with the 2022 Malaysian Company of the Year Award

Duopharma Biotech is the first pharmaceutical company to offer biosimilar products in the Malaysian market. SAN ANTONIO, July 27, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the Malaysian biosimilars industry and, based on its findings, recognizesDuopharma Biotech Berhad (Duopharma...

2023-07-27 14:00 1391

Acceptance Of Clinical Trial Application For The Recbio's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In China And Overseas Clinical Trial Progress

TAIZHOU, China, July 27, 2023 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the"Board") is pleased to announce that the Group has recently received the notice of acceptance (acceptance number: CXSL2300518) issued by National Medical Products Administration ("NMPA"), pursuant to which the c...

2023-07-27 10:57 3856

Everest Medicines Announces Commercial Launch and First Prescription for XERAVA® in China

Everest transforms into a commercial-stage innovative biopharmaceutical company SHANGHAI, July 27, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicin...

2023-07-27 08:10 1811

SK Inc.'s board of directors declares an interim dividend of KRW 1,500 per share

* The first interim dividend payout after Articles of Incorporation were amended to enable investors to invest after checking dividend amount * Shareholders of record as of August 10, 2023 will receive dividend payout  SEOUL, South Korea, July 27, 2023 /PRNewswire/ -- SK Inc. announced that it...

2023-07-27 08:00 1630

YS Biopharma Announces Financial Results for Fiscal Year 2023 Ended March 31, 2023

Total revenues increase by 36.3% year-over-year; gross margin improves to 77.7%; balance sheet remains robust Company's PIKA rabies vaccine approved for Phase III clinical trials in Singapore, the Philippines, and Pakistan; interim results expected early next year GAITHERSBURG, Md., July 27, 20...

2023-07-27 05:00 4155

Hummingbird Bioscience Initiates HMBD-001 Phase IB Trials in Australia and Partners with Omico to Accelerate Clinical Development

* Hummingbird Bioscience has initiated two clinical trials in Australia evaluating HMBD-001 in patients with squamous non-small cell lung cancer and patients with genetic aberrations in HER3 signaling * Hummingbird Bioscience has identified genetic signatures that are predictive of response t...

2023-07-27 04:00 1716

CartiHeal Announces First Commercial Implantation of Agili-C™ in the US

KFAR SABA, Israel, July 26, 2023 /PRNewswire/ -- CartiHeal Ltd. , developer of implants for the treatment of cartilage and osteochondral defects in arthritic and non-arthritic knee-joints, today announced its first commercial implantation of Agili-C in the US by Dr. Ken...

2023-07-26 21:04 1551

Philips Future Health Index 2023 Report: APAC's healthcare sector embracing new care delivery model to tackle financial pressures and staff shortages

* Largest global survey of its kind finds investment in smart and connected digital health technologies and expansion of virtual care towards new models of care are top priorities for the region. * Healthcare professionals in APAC are counting on new care delivery models to enable better pati...

2023-07-26 16:05 1853

World's first*1 report: A potential effectiveness of Plasmacluster Technology that may induce brain activation

Validation of the mechanism of its enhancing effect on human work performance by measuring brain function *2 OSAKA, Japan, July 26, 2023 /PRNewswire/ -- Sharp Corporation conducted collaborative research on its Plasmacluster technology, with Dr.Goichi Hagiwara , Associate Professor, Faculty of Hu...

2023-07-26 14:15 1609

Alma, a Sisram Medical Company, Announces the Launch of Alma Veil™ for the U.S. Market

HONG KONG and CHICAGO, July 25, 2023 /PRNewswire/ -- Alma, a global leader in the energy-based medical and aesthetic solutions industry, proudly announces the commercial availability of Alma Veil™. This advanced, dual-wavelength vascular laser workstation establishes a new standard in excellence ...

2023-07-25 22:10 1682

Fapon Launches the Most Efficient Chemiluminescence Immunoassay Analyzer to Date with Throughput of 900 T/h

ANAHEIM, Calif., July 25, 2023 /PRNewswire/ -- Fapon, a global leading life sciences company, has announced the launch of its latest chemiluminescence immunoassay system Shine i8000/9000 to global markets at the 2023 AACC exhibition. The high-speed and fully automated analyzer has an ultra-high ...

2023-07-25 20:07 1425

RemeGen's Telitacicept Shows Significant Promise in Phase II Trial for Primary Sjogren's Syndrome: Findings Published in Prestigious Rheumatology Journal

YANTAI, China, July 25, 2023 /PRNewswire/ -- RemeGen Co., Ltd.  ("RemeGen" or "the Company") (HKG: 9995, SHA: 688331), a fully-integrated commercial-stage biotechnology company, has announced that their Phase II clinical study of telitacicept (RC18) for the treatment of ...

2023-07-25 16:00 1535

Duopharma Biotech Applauded by Frost & Sullivan for Providing Innovative Healthcare Solutions in the Malaysian Market

Duopharma Biotech is a worldwide pioneer in the research and development of halal pharmaceuticals. SAN ANTONIO, July 25, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the Malaysian halal pharmaceutical industry and, based on its findings, recognizesDuopharma Biotech Berhad (Duopharma...

2023-07-25 14:00 1474

Clinical Results of ASC22 (Envafolimab) in Combination with Chidamide for Functional Cure of HIV Infection Presented at the 12th IAS Conference on HIV Science

HANGZHOU and SHAOXING, China, July 25, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that Shanghai Public Health Clinical Center presented clinical results of ASC22 (Envafolimab) in combination with Chidamide for functional cure of human immunodeficiency virus...

2023-07-25 08:10 1831

Fapon to Showcase Innovative Diagnostic and Biopharma Solutions at 2023 AACC Expo

ANAHEIM, Calif., July 24, 2023 /PRNewswire/ -- Fapon, a leading life science company, will showcase its latest innovations in in-vitro diagnostic and biopharma solutions at the 2023 American Association of Clinical Chemistry (AACC) Scientific Meeting and Clinical Lab Expo fromJuly 25 to 27. At t...

2023-07-24 21:58 1793

Biocon Biologics Announces Positive CHMP Opinion for YESAFILI®, Biosimilar Aflibercept

BRIDGEWATER, N.J. and BENGALURU, India, July 24, 2023 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion r...

2023-07-24 18:30 1468

Apollo leads India's Solid Multi-Organ Transplantation with over 23000 transplants, establishes global leadership

Apollo performs the highest number of solid organ transplants in the world per year NEW DELHI, July 24, 2023 /PRNewswire/ -- Apollo, the world's largest vertically integrated healthcare provider, has achieved a momentous feat by completing 23,000 transplants. The Apollo Transplant Program stands...

2023-07-24 14:30 1533

Project Matty: Revolutionizing Care for Children with Autism and ADHD Through AI

SINGAPORE, July 24, 2023 /PRNewswire/ -- Project Matty, a pioneering digital health solution, has been launched by a dedicated mother of an ADHD-diagnosed child and Dr.Pamela Lim, a clinical psychology doctor. Both inspired by their personal experiences and united by their commitment to improve t...

2023-07-24 12:11 2217

BGI Genomics Global Cervical Cancer Survey Finds Young Women Have Higher Vaccination Rates but 43.5 percent Put off by Pap Smears

* Vaccination and Screening Form a Virtuous Cycle to Combat Cervical Cancer HONG KONG, July 24, 2023 /PRNewswire/ -- To further inform action to combat cervical cancer, the fourth most common cancer among women globally, BGI Genomics released its State of Cervical Cancer Awareness Report today....

2023-07-24 10:30 2305

ConcertAI's TeraRecon Expands Relationship with Change Healthcare for Advanced Visualization Offering in Australia

The expanded agreement allows providers to locally acquire TeraRecon's solutions CAMBRIDGE, Mass., July 24, 2023 /PRNewswire/ -- Advanced visualization and AI leader TeraRecon, a ConcertAI company, is excited to announce an expansion of its reseller and service agreement inAustralia with Change H...

2023-07-24 04:30 1879
1 ... 53545556575859 ... 383